These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 14238599)

  • 1. [REPORT ON THE CLINICAL TESTING OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].
    LEUBNER H
    Arzneimittelforschung; 1964 May; 14():404-6. PubMed ID: 14238599
    [No Abstract]   [Full Text] [Related]  

  • 2. [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].
    GUTSCHE H; BOENICKE G
    Arzneimittelforschung; 1964 May; 14():409-11. PubMed ID: 14238601
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN). EXPERIENCES WITH 160 DIABETICS].
    ROBBERS H; BRUMBY KH; TRAUMANN KJ
    Arzneimittelforschung; 1964 May; 14():406-9. PubMed ID: 14238600
    [No Abstract]   [Full Text] [Related]  

  • 4. [ORAL THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN)].
    BERNHARD H
    Arzneimittelforschung; 1964 May; 14():411-2. PubMed ID: 14238602
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE BEHAVIOR OF LIVER GLYCOGEN IN DIABETES IN AGED SUBJECTS UNDER THE INFLUENCE OF INSULIN AND THE ORAL ANTIDIABETIC 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PY RIMIDINE (GLYCODIAZIN)].
    BERINGER A; THALER H
    Arzneimittelforschung; 1964 May; 14():403-4. PubMed ID: 14238598
    [No Abstract]   [Full Text] [Related]  

  • 6. [PHARMACOLOGY OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING COMPOUND].
    KRAMER M; HECHT G; LANGECKER H; HARWART A; RICHTER KD; GLOXHUBER C
    Arzneimittelforschung; 1964 May; 14():377-85. PubMed ID: 14238594
    [No Abstract]   [Full Text] [Related]  

  • 7. [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING AGENT. I. THE METABOLISM OF GLYCODIAZIN IN MAN].
    GERHARDS E; GIBIAN H; KOLB KH
    Arzneimittelforschung; 1964 May; 14():394-402. PubMed ID: 14238597
    [No Abstract]   [Full Text] [Related]  

  • 8. [TOLERANCE OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN LONG-TERM ADMINISTRATION IN ANIMAL EXPERIMENTS].
    KRAMER M; HECHT G; GUENZEL P; HARWART A; RICHTER KD; GLOXHUBER C
    Arzneimittelforschung; 1964 May; 14():389-94. PubMed ID: 14238596
    [No Abstract]   [Full Text] [Related]  

  • 9. [RESORPTION, DISTRIBUTION AND EXCRETION OF RADIOACTIVE-LABELLED 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN ANIMAL EXPERIMENTS].
    KOLB KH; KRAMER M; SCHULZE PE
    Arzneimittelforschung; 1964 May; 14():385-9. PubMed ID: 14238595
    [No Abstract]   [Full Text] [Related]  

  • 10. [CLINICAL EXPERIENCES WITH A NEW ORAL HYPOGLYCEMIC DRUG, ACETOHEXAMIDE].
    CHANIS RA
    Arch Med Panamenos; 1963 Dec; 12():193-206. PubMed ID: 14161953
    [No Abstract]   [Full Text] [Related]  

  • 11. [REMARKS APROPOS OF THE BIGUANIDE-HYPOGLYCEMIC SULFONAMIDE COMBINATION IN PHARMACOLOGY AND CLINICAL PRACTICE].
    STERNE J; HIRSCH C
    Therapie; 1964; 19():563-9. PubMed ID: 14182941
    [No Abstract]   [Full Text] [Related]  

  • 12. ACETOHEXAMIDE: CLINICAL EVALUATION OF A NEW ORAL ANTIDIABETIC AGENT.
    ALTERMAN SL; LIEBER AL
    Curr Ther Res Clin Exp; 1964 Mar; 6():148-55. PubMed ID: 14131413
    [No Abstract]   [Full Text] [Related]  

  • 13. [SULFONAMIDOPYRIMIDINES, A NEW GROUP OF BLOOD SUGAR-LOWERING COMPOUNDS].
    GUTSCHE K; HARWART A; HORSTMANN H; PRIEWE H; RASPE G; SCHRAUFSTAETTER E; WIRTZ S; WOERFFEL U
    Arzneimittelforschung; 1964 May; 14():373-6. PubMed ID: 14238593
    [No Abstract]   [Full Text] [Related]  

  • 14. ACETOHEXAMIDE ('DIMELOR') IN DIABETES.
    HERMAN M; JACKSON WP
    S Afr Med J; 1964 Jul; 38():519-22. PubMed ID: 14182168
    [No Abstract]   [Full Text] [Related]  

  • 15. [2 CASES OF HEMIPLEGIA INDICATIVE OF SEVERE HYPOGLYCEMIA INDUCED BY HYPOGLYCEMIC SULFONAMIDES].
    HAZARD J; DOMART A
    Bull Mem Soc Med Hop Paris; 1965 Feb; 116():473-6. PubMed ID: 14308218
    [No Abstract]   [Full Text] [Related]  

  • 16. CLINICAL TRIAL OF GLYCODIAZINE, A NEW ORAL ANTIDIABETIC AGENT.
    SZANTO S
    J Ir Med Assoc; 1965 Jun; 56():180-3. PubMed ID: 14327215
    [No Abstract]   [Full Text] [Related]  

  • 17. TRIAL OF A NEW ORAL ANTIDIABETIC DRUG--GLYCODIAZINE.
    ROE PF
    J Ir Med Assoc; 1965 Jun; 56():183-5. PubMed ID: 14327216
    [No Abstract]   [Full Text] [Related]  

  • 18. COMBINED TRIAL OF ACETOHEXAMIDE AND TWO DIGUANIDE PREPARATIONS.
    SZANTO S
    Ir J Med Sci; 1964 Jan; 457():3-11. PubMed ID: 14113902
    [No Abstract]   [Full Text] [Related]  

  • 19. [CLINICAL FINDINGS ON THE BEHAVIOR OF THE TOLBUTAMIDE TEST AFTER TREATMENT WITH HYDROCHLOROTHIAZIDE IN PRESENILE AND SENILE SUBJECTS].
    GARELLA S
    Minerva Med; 1964 Oct; 55():3371-4. PubMed ID: 14225471
    [No Abstract]   [Full Text] [Related]  

  • 20. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.